Drugs for Lice Infestation (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 37)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
2 |
|
Ethanol |
Approved |
Phase 3 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
3 |
|
Benzyl alcohol |
Approved |
Phase 3 |
|
100-51-6 |
244 |
Synonyms:
(Hydroxymethyl)benzene
.alpha.-hydroxytoluene
.alpha.-toluenol
a-Hydroxytoluene
Alcohol, benzyl
Alcoholum benzylicum
Alcool benzylique
Alcoolbenzylique
alpha-Hydroxytoluene
alpha-Toluenol
Aromatic alcohol
Aromatic primary alcohol
a-Toluenol
Bentalol
Benzal alcohol
Benzalalcohol
Benzalcohol
Benzenecarbinol
Benzenemethanol
Benzenmethanol
Benzoyl alcohol
Benzyl alcohol
Benzyl alkohol
|
Benzylalcohol
Benzyl-alcohol
Benzylalkohol
Benzylic alcohol
Benzylicum
Caswell no. 081F
Enzylalcohol
Euxyl K 100
Hydroxymethylbenzene
Hydroxytoluene
Itch-X
MBN
Methanol benzene
Phenolcarbinol
Phenylcarbinol
Phenylcarbinolum
Phenylmethanol
Phenylmethyl alcohol
Sunmorl BK 20
TB 13g
Ulesfia
Α-hydroxytoluene
Α-toluenol
|
|
4 |
|
Ivermectin |
Approved, Investigational, Vet_approved |
Phase 3 |
|
70288-86-7 |
9812710 6427057 |
Synonyms:
CARDOMEC
CD5024
CD-5024
EQVALAN
Heartgard®|ivermectin B<sub>1a</sub>|MK-933|Sklice®|Soolantra®
HEARTGUARD
IVERMECTIN
IVERMECTIN COMPONENT B1A
Ivermectina
Ivermectine
|
Ivermectinum
IVOMEC
L 640471
L-640471
MECTIZAN
MK 933
MK-933
SKLICE
SOOLANTRA
STROMECTOL
|
|
5 |
|
Malathion |
Approved, Investigational |
Phase 3 |
|
121-75-5 |
4004 |
Synonyms:
[(Dimethoxyphosphinothioyl)thio]butanedioate diethyl ester
[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester
8059HC
Carbafos
Carbofos
Carbophos
Compound 4049
Cythion
DERBAC-M
DIETHYL (DIMETHOXYPHOSPHINOTHIOYLTHIO) SUCCINATE
Diethyl (dimethoxyphosphinothioylthio)succinate
Diethyl (dimethoxyphosphinothioylthio)succinic acid
ENT 17,034
ENT-17034
Experimental insecticide 4049
Insecticide no. 4049
Karbofos
MALATHION
Malathione
Maldison
Mercaptosuccinic acid diethyl ester
|
Mercaptothion
Mercaptotion
MLT
NSC-6524
O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)
O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate
O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphoric acid
O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate
O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioic acid
O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl
O,O-Dimethyldithiophosphate diethylmercaptosuccinate
O,O-Dimethyldithiophosphoric acid diethylmercaptosuccinic acid
Oleophosphothion
ORGANODERM
Ovide
Prioderm
QUELLADA-M
S-[1,2-BIS(ETHOXYCARBONYL) ETHYL]O,O-DIMETHYL-PHOSPHORODITHIOATE
Sadophos
SULEO-M
|
|
6 |
|
Permethrin |
Approved, Investigational |
Phase 3 |
|
52645-53-1 |
40326 |
Synonyms:
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid
(3-Phenoxyphenyl)methyl (±)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(m-Phenoxybenzyl)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylate, (3-phenoxyphenyl) methyl ester
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyl-(+-)-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester
3-Phenoxybenzyl-cis,trans-(1Rs)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
Ambush
cis Permethrin
cis-(1Rs)-Permethrin
cis-Permethrin
Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester
Elimite
LYCLEAR
LYTHRIN
Nittifor
NIX
NRDC 143
|
NRDC 147
NRDC143
NRDC-143
NRDC147
NRDC-147
PERMETHRIN
Permethrin, (1R-cis)-isomer
Permethrin, (1R-trans)-isomer
Permethrin, (1S-cis)-isomer
Permethrin, (1S-trans)-isomer
Permethrin, (cis-(+-))-isomer
Permethrin, (cis)-isomer
Permethrin, (trans-(+-))-isomer
Permethrin, (trans)-isomer
Permethrin, cis-(1Rs)-isomer
Permethrin, trans-(1Rs)-isomer
trans Permethrin
trans-(1Rs)-Permethrin
trans-Permethrin
|
|
7 |
|
Rue |
|
Phase 3 |
|
|
|
8 |
|
Anesthetics, Local |
|
Phase 3 |
|
|
|
9 |
|
Anesthetics |
|
Phase 3 |
|
|
|
10 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
11 |
|
Antiparasitic Agents |
|
Phase 3 |
|
|
|
12 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
13 |
|
Cholinesterase Inhibitors |
|
Phase 3 |
|
|
|
14 |
|
Cholinergic Agents |
|
Phase 3 |
|
|
|
15 |
|
Anti-Infective Agents, Local |
|
Phase 3 |
|
|
|
16 |
|
Pulmonary Surfactants |
|
Phase 3 |
|
|
|
17 |
|
Neem |
|
Phase 2 |
|
|
|
18 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 1 |
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Β)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Β oestradiol
17Β-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Β-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Β-estradiol
|
|
19 |
|
Ethinylestradiol |
Approved |
Phase 1 |
|
57-63-6 |
5991 |
Synonyms:
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
17 ALPHA-ETHINYLESTRADIOL
17 ALPHA-ETHYNYLESTRADIOL
17 ALPHA-ETHYNYLOESTRADIOL
17α-ethynylestradiol|ethinyl estradiol
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17Α-ethinyl estradiol
17Α-ETHYNYLESTRADIOL
Alora
Amenoron
Anovlar
Chee-O-gen
Chee-O-genf
Diognat-e
Diogyn e
Diogyn-e
Dyloform
Effik brand OF ethinyl estradiol
ENOVID
ENOVID-E
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Eston-e
Estoral
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl estradiol
Ethinyl estradiol hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinylestradiol
Ethinylestradiol jenapharm
ETHINYLESTRADIOLUM
Ethinylestriol
Ethinyloestradiol
|
Ethinyl-oestradiol effik
ETHINYL-OESTRANOL
Ethynyl estradiol
Ethynylestradiol
ETHYNYLOESTRADIOL
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
ETINILESTRADIOL
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm, ethinylestradiol
Kolpolyn
Linoral
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Neo-estrone
Nogest-S
NORINYL
Novestrol
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Ovex
OVULEN
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Progynon C
Progynon m
Schering brand OF ethinyl estradiol
Schering-plough brand OF ethinyl estradiol
Spanestrin
Thiuram e
Thiuranide
Vagifem
Ylestrol
|
|
20 |
|
Polyestradiol phosphate |
Approved |
Phase 1 |
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
21 |
|
Norgestimate |
Approved, Investigational |
Phase 1 |
|
35189-28-7 |
6540478 |
Synonyms:
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(17a)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17Α)-17-(acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
D-13b-Ethyl-17a-ethynyl-17b-acetoxygon-4-en-3-one oxime
|
D-13Β-ethyl-17α-ethynyl-17β-acetoxygon-4-en-3-one oxime
DEXNORGESTREL
Dexnorgestrel acetime
dexnorgestrel|ORF-10131|RWJ-10131
NORGESTIMATE
Norgestimato
Norgestimatum
Norgestimic acid
Norgestrel oxime acetate
ORF-10131
RWJ-10131
|
|
22 |
|
Moxifloxacin |
Approved, Investigational |
Phase 1 |
|
186826-86-8, 354812-41-2, 151096-09-2 |
152946 |
Synonyms:
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Actira
Avalox
Avelox
AVELOX I.V.
BAY 12-8039
|
Izilox
MOXIFLOXACIN
Moxifloxacin HCl
Moxifloxacin hydrochloride
Moxifloxacino
Octegra
Proflox
VIGAMOX
|
|
23 |
|
Anti-Bacterial Agents |
|
Phase 1 |
|
|
|
24 |
|
Estradiol 3-benzoate |
|
Phase 1 |
|
|
|
25 |
|
Estradiol 17 beta-cypionate |
|
Phase 1 |
|
|
|
26 |
|
Contraceptives, Oral, Combined |
|
Phase 1 |
|
|
|
27 |
|
Contraceptives, Oral |
|
Phase 1 |
|
|
|
28 |
|
Contraceptive Agents |
|
Phase 1 |
|
|
|
29 |
|
Norgestimate, ethinyl estradiol drug combination |
|
Phase 1 |
|
|
|
30 |
|
Azithromycin |
Approved |
|
|
83905-01-5 |
447043 |
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
Azadose
AZASITE
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
AZITHROMYCIN
AZITHROMYCIN ANHYDROUS
Azithromycin dihydrate
AZITHROMYCIN HYDRATE
Azithromycin monohydrate
Azithromycin pfizer brand
Azithromycine
Azithromycinum
Azitrocin
Azitromicina
Azitromin
AZYTER
Azythromycin
Bayer brand OF azithromycin dihydrate
CLAMELLE
CP 62993
|
CP-62,993
CP-62993
Dihydrate, azithromycin
Funk brand OF azithromycin dihydrate
Goxal
Hemomycin
Lesvi brand OF azithromycin dihydrate
Mack brand OF azithromycin dihydrate
Monohydrate, azithromycin
Pfizer brand OF azithromycin
Pfizer brand OF azithromycin dihydrate
Pharmacia brand OF azithromycin dihydrate
Sumamed
SUNAMED
Toraseptol
Ultreon
Vinzam
Vita brand OF azithromycin dihydrate
XZ 405
XZ 450
XZ-450
Zentavion
Zithromax
Zitromax
Zmax
|
|
31 |
|
Albendazole |
Approved, Vet_approved |
|
|
54965-21-8 |
2082 |
Synonyms:
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamate methyl ester
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
Albendazol
Albendazole
Albendazole armstrong brand
Albendazole diba brand
Albendazole fustery brand
Albendazole hormona brand
Albendazole liferpal brand
Albendazole monohydrochloride
Albendazole noé-socopharm brand
Albendazole pfizer brand
Albendazole sanicoopa brand
Albendazole valdecasas brand
Albendazolum
Albendoral
Albenza
Andazol
Armstrong brand OF albendazole
Bendapar
Bilutac
Diba brand OF albendazole
Digezanol
Disthelm
Disthelm, mediamix V
Endoplus
Eskazole
Fustery brand OF albendazole
|
Gascop
Hormona brand OF albendazole
Liferpal brand OF albendazole
Lurdex
Mediamix V disthelm
Metiazol
Monohydrochloride, albendazole
Noé socopharm brand OF albendazole
Noé-socopharm brand OF albendazole
NSC-220008
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamic acid
Pfizer brand OF albendazole
Proftril
RICOBENDAZOLE
RYCOBENDAZOLE
Sanicoopa brand OF albendazole
SK And F 62979
SK And F62979
SK And F-62979
SK&F 62979
SK&F-62979
SmithKline beecham brand OF albendazole
V Disthelm, mediamix
Valbazen
Valdecasas brand OF albendazole
ZENTAL
Zentel
|
|
32 |
|
Antimitotic Agents |
|
|
|
|
|
33 |
|
Antiprotozoal Agents |
|
|
|
|
|
34 |
|
Anthelmintics |
|
|
|
|
|
35 |
|
Tubulin Modulators |
|
|
|
|
|
36 |
|
Bee Products |
|
|
|
|
|
37 |
|
Propolis |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 55)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Single Treatment, Pharmacokinetic (PK) and Tolerance Study of Natroba (Spinosad) Topical Suspension, 0.9% in Pediatric Subjects 6 Months to 4 Years of Age With an Active Head Lice Infestation |
Completed |
NCT01660321 |
Phase 4 |
spinosad |
2 |
A Randomised, Assessor Blind, Parallel Group, Comparative Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application |
Completed |
NCT00995124 |
Phase 4 |
NeutraLice Lotion;NeutraLice Advance Solution;Moov Head Lice Solution |
3 |
Phase 3 Efficacy and Safety Study for PIOLIN® Shampoo to Treat Pediculosis |
Unknown status |
NCT01966965 |
Phase 3 |
PIOLIN®;NEDAX |
4 |
A Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation |
Completed |
NCT02062060 |
Phase 3 |
Abametapir Lotion 0.74% w/w;Vehicle Lotion |
5 |
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation |
Completed |
NCT02060903 |
Phase 3 |
Abametapir Lotion 0.74% w/w;Vehicle Lotion |
6 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Ivermectin Lotion 0.5% (Actavis Laboratories UT, Inc.) to SKLICE® (Ivermectin) Lotion, 0.5% (Arbor Pharmaceuticals, LLC) in the Treatment of Human Head Lice Infestation |
Completed |
NCT03301649 |
Phase 3 |
Generic Ivermectin Lotion 0.5%;Sklice® (Ivermectin) Lotion 0.5%;Vehicle Lotion |
7 |
A Randomised, Double-Blind, Multicentre Study to Compare the Efficacy and Tolerability of Oral Ivermectin to Malathion 0.5% Lotion in the Treatment of Head Lice Infestation |
Completed |
NCT00819520 |
Phase 3 |
ivermectin;malathion |
8 |
A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects >6 Months of Age or Older With Pediculosis Capitis |
Completed |
NCT00545753 |
Phase 3 |
Spinosad;Permethrin 1% |
9 |
Phase II, Multi-Center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis |
Completed |
NCT00752973 |
Phase 2, Phase 3 |
MALG (malathion) Treatment |
10 |
A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects > 6 Months of Age With Pediculosis Capitis |
Completed |
NCT00545168 |
Phase 3 |
Spinosad;Permethrin 1% |
11 |
A Multi-Center Phase III Study to Evaluate MALG, a Novel Malathion 0.05%Formulation, for the Control of Head Lice in Pediatric and Adult Subjects With Pediculosis Capitis |
Completed |
NCT00244439 |
Phase 3 |
MALG;Ovide (malathion) lotion 0.05%;Permethrin 1% |
12 |
A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis |
Completed |
NCT00963508 |
Phase 3 |
Malathion gel 0.5%;Permethrin 1% rinse (Nix Crème) |
13 |
A Multi-Center Phase III Study to Evaluate Ovide Lotion 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis |
Completed |
NCT00927472 |
Phase 3 |
Malathion gel 0.5%;Permethrin 1% rinse |
14 |
A Randomised, Controlled and Blinded Assessment Study of the Efficacy of MOOV Head Lice Treatment (Ego Pharmaceutical Pty. Ltd.) in the Treatment of Head Lice in Primary School Children. |
Completed |
NCT00381082 |
Phase 2, Phase 3 |
1) MOOV Head Lice Treatment (Ego Pharmaceutical).;Banlice Mousse Aerosol (Pfizer, Australia);3) KP24 Medicated Foam (Nelson Laboratories) |
15 |
A Multi-Center, Randomized, Vehicle Controlled, Double Blind Clinical Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice. |
Completed |
NCT00479310 |
Phase 3 |
Summers 5% L.A. |
16 |
A Randomized, Multi-Center, Double-blind, Placebo Controlled, Parallel Group Trial to Evaluate Efficacy and Safety of Mayne Pharma's Ivermectin 0.5% Lotion Compared to Sklice® Ivermectin 0.5% Lotion in the Treatment of Head Lice |
Completed |
NCT03337490 |
Phase 3 |
Ivermectin 0.5% Topical Application Lotion;Ivermectin 0.5% Topical Application Lotion [SKLICE];Placebo 0% Lotion |
17 |
Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova. |
Completed |
NCT02624843 |
Phase 3 |
Benzyl Alcohol Lotion 5%;Ulesfia (benzyl alcohol lotion) 5%;Placebo |
18 |
An Open Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice |
Completed |
NCT00301340 |
Phase 3 |
5% Lice Asphyxiator lotion - Summers Laboratories, Inc. |
19 |
A Multi-Center, Randomized, Vehicle Controlled, Double Blind Clinical Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice. |
Completed |
NCT00301327 |
Phase 3 |
Summers 5% L.A. |
20 |
A Double-Blind Randomized Study to Compare the Efficacy, Safety and Local Tolerability of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation |
Completed |
NCT01066585 |
Phase 3 |
Ivermectin Cream;vehicle control |
21 |
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands |
Completed |
NCT03236168 |
Phase 3 |
Ivermectin;Permethrin 5%;Malathion Shampoo 0.5% |
22 |
A Randomised, Controlled, Assessor-blind, Parallel Group Clinical Trial to Assess the Efficacy, Safety and Acceptability of a Surfactant Based Lotion and a Permethrin Creme Rinse in the Treatment of Head Lice |
Terminated |
NCT02500524 |
Phase 3 |
Cocamide diethanolamine;Permethrin |
23 |
A Randomised, Parallel Group Clinical Trial to Assess the Efficacy, Safety and Acceptability of a Surfactant Based Lotion in the Treatment of Head Louse Infection. |
Terminated |
NCT02499549 |
Phase 2, Phase 3 |
cocamide diethanolamine |
24 |
A Pediatric Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation |
Completed |
NCT02010333 |
Phase 2 |
Ha44 Gel 0.74% w/w |
25 |
A Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically Under Maximal Use Conditions for the Treatment of Head Lice Infestation. |
Completed |
NCT01907490 |
Phase 2 |
Ha44 Gel |
26 |
A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation |
Completed |
NCT02097485 |
Phase 2 |
Abametapir Lotion 0.74% w/w;Vehicle Lotion |
27 |
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial On The Efficacy And Safety Of Topical 0.5% Ivermectin Lotion For The Treatment Of Head Lice Infestation Among Filipino Children Age 3 Years Or Older |
Completed |
NCT03286101 |
Phase 2 |
0.5% Ivermectin lotion;Vehicle |
28 |
A Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of 3 Strengths of Ivermectin Treatment Conditioner and Placebo in Subjects With Pediculus Humanus Capitis (Head Lice) Infestation |
Completed |
NCT00857948 |
Phase 2 |
ivermectin treatment conditioner;Placebo, vehicle control |
29 |
A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation |
Completed |
NCT00528021 |
Phase 2 |
Placebo;BGC20-0582 |
30 |
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation |
Completed |
NCT01336647 |
Phase 2 |
Group A - Low-Dose Ha44 0.37% w/w;Group B - High Dose Ha44 Gel 0.74% w/w;Group C - Placebo |
31 |
Efficacy and Safety of Different Strengths of Spinosad Topical Creme (0%, 0.5%, 1.0% or 2%) in Subjects With Pediculosis Capitis - a Dose Ranging Study |
Completed |
NCT00858481 |
Phase 2 |
Spinosad Creme Rinse - Vehicle Control;Spinosad Creme Rinse |
32 |
A Pilot Study to Test the Operational Elements of an Actual Use Study Designed to Compare the Safety and Efficacy of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months of Age or Older With Pediculosis Capitis |
Completed |
NCT00857935 |
Phase 2 |
NatrOVA Creme Rinse - 1%;NIX Creme Rinse - 1% permethrin |
33 |
Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study |
Completed |
NCT00311779 |
Phase 2 |
Spinosad Creme Rinse |
34 |
A Randomised, Assessor Blinded "Proof of Concept" (Phase IIa) Clinical Study to Assess the Efficacy and Safety of Nice 'n Clear Head Lice Lotion in the Treatment of Head Lice |
Completed |
NCT02974088 |
Phase 2 |
|
35 |
Safety and Efficacy of a 100% Dimethicone Pediculocide in School-Age Children |
Completed |
NCT02213055 |
Phase 2 |
LICEMD;Standard Head lice product |
36 |
Phase II, Multi-center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis |
Terminated |
NCT00291057 |
Phase 2 |
MALG |
37 |
An Open-label Study to Assess the Bioavailability, Safety, Local Tolerance, and Efficacy of 0.5% Ivermectin Cream in Subjects 6 Months to 3 Years of Age With Pediculus Humanus Capitis (Head Lice) Infestation |
Completed |
NCT00988533 |
Phase 1 |
0.5% Ivermectin Cream |
38 |
A Randomized, Single-Dose, Parallel Group, Comparative Pharmacokinetic (PK) Study to Evaluate Malathion Gel 0.5% Versus Ovide (Malathion) Lotion 0.5% in Patients With Pediculosis Capitis |
Completed |
NCT00927407 |
Phase 1 |
Malathion gel 0.5%;Malathion lotion 0.5% |
39 |
A Phase 1B Single Treatment, Pharmacokinetic and Tolerance Study of NatroVA Topical Creme (1%) i Pediatric Subjects 6 to 24 Months of Age |
Completed |
NCT00410709 |
Phase 1 |
NatrOVA Creme Rinse (1%) |
40 |
A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Effect of Ha44 Gel on the ECG in Healthy Adult Subjects |
Completed |
NCT01518699 |
Phase 1 |
Ha44;Ha44 Placebo;Moxifloxacin Placebo;Moxifloxacin |
41 |
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-group Study, Comparing Ivermectin Lotion, 0.5% in the Treatment of Subjects With Active Infestation With Head Lice and Their Ova |
Completed |
NCT03257943 |
Phase 1 |
Ivermectin Lotion, 0.5%;SKLICE (ivermectin) Lotion, 0.5%;Vehicle of the Test product |
42 |
Clinical Trial of Anti-Lice Treatment Using the Medical Device "No More" Which is Designed to Kill Lice and Lice Eggs on the Head. |
Unknown status |
NCT02569580 |
|
|
43 |
Treatment of Head Lice Infestation Using Novel Ultrasonic Comb |
Completed |
NCT02854878 |
|
|
44 |
Scalp Pruritus Measurement Using Visual Analog Scale and 5-d Itch Scale in Children With Pediculosis Capitis |
Completed |
NCT04415034 |
|
|
45 |
Study of the Therapeutic Efficacy of the Combination Azithromycin + Ivermectin in the Treatment of Pediculosis in Senegal (IVERAZITH) |
Completed |
NCT03578679 |
|
Ivermectin Oral Product |
46 |
Control of Head Lice in Children and Adults |
Completed |
NCT00731718 |
|
|
47 |
Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren |
Completed |
NCT00207753 |
|
albendazole vs. combined albendazole/ivermectin treatment |
48 |
A Randomized, Controlled, Investigator-Assessor Blinded, Comparative Study to Evaluate the Safety and Efficacy of a Water-Soluble Head Lice Suffocation Product (X92001666) vs RID Shampoo (Pyrethrin) in Subjects With Head Lice |
Completed |
NCT03617926 |
|
|
49 |
A Comparative Study to Demonstrate the Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin in Head Lice Infested Individuals |
Completed |
NCT01514513 |
|
Licefreee Spray;1% permethrin creme rinse |
50 |
An Open Label Randomized Study to Compare the Safety and Efficacy of Silcap Plus (Approximately 4% Dimeticone) Against Nix Cream Rinse. |
Completed |
NCT00672971 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
ANISE OIL/CORIANDER OIL/LEMON OIL/ORANGE OIL
Benzyl Alcohol
Ivermectin
Lindane
Malathion
|
Pediculicide [EPC]
Permethrin
Piperonyl Butoxide
spinosad
|
|